Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Thoma Bravo to take Dayforce private

The Wall Street Journal on MSN · 21h
Thoma Bravo to Buy Dayforce for $11.2 Billion
Dayforce has agreed to be acquired by private-equity firm Thoma Bravo in a deal that values the provider of human-resources software at around $11.2 billion.
Reuters on MSN · 9h
Dayforce to go private in $12.3 billion Thoma Bravo acquisition
By Milana Vinn (Reuters) -Private equity firm Thoma Bravo has agreed to buy human resources software provider Dayforce for $12.3 billion, including debt, in a take-private deal that executives hope will help expand on the company's AI capabilities.
Markets Insider · 21h
Dayforce Enters into US$12.3 Billion Definitive Agreement with Thoma Bravo to Become a Private Company
Dayforce Stockholders to Receive US$70 Per Share in Cash, a 32% Premium to the Unaffected Share PriceTransaction Aims to Accelerate Dayforce’s
3d

Private Equity Powerhouse Eyes Dayforce in Billion-Dollar Deal

Private equity giant Thoma Bravo is reportedly circling Dayforce, a $1.76B cloud HCM leader, in what could be a landmark deal ...
12hon MSN

Goldman Sachs pledges $6B debt package for Thoma Bravo's Dayforce takeover - report

Goldman Sachs (NYSE:GS) has lined up a $6B debt financing package to back private equity firm Thoma Bravo's acquisition of HR ...
StockStory.org on MSN3d

Why Are Dayforce (DAY) Shares Soaring Today

What Happened? Shares of human capital management software company Dayforce (NYSE:DAY) jumped 27.6% in the afternoon session ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy